Introduction: COVID-19 is a global public health emergency that can cause acute respiratory distress syndrome. In countries where tuberculosis (TB) is endemic, coinfection of COVID-19 and TB is often encountered, which increases the risk of developing severe forms of COVID-19. Objectives: The aim of this study was to determine the prevalence of COVID-19/TB coinfection at the Epidemic treatment center (ETC) in Saint-Louis (Senegal) and to describe the epidemiological, clinical, paraclinical, and outcome profile of co-infected patients. Patients and Methods: This is a retrospective, cross-sectional, descriptive cohort study based on the records of COVID-19/ TB co-infected patients who were hospitalized at the ETC in Saint-Louis (Senegal) over an 18-month period from March 2020 to September 2021. Results: Out of a total of 454 hospitalizations, we collected records of 9 patients co-infected with COVID-19/TB, resulting in a prevalence of 2%. The study included patients with a median age of 34 years (range: 10-86 years), with a male predominance (7 cases) and a sex ratio of 3.5. The majority of patients (88.9%) had severe forms of COVID-19. Dyspnea and cough were reported in all patients (100%). Pulmonary TB was the most frequent localization, with 9 cases. The diagnosis of COVID-19 was confirmed by nasopharyngeal PCR in all patients (100%). Bacilloscopy was positive in 3 out of 5 cases. One patient tested positive for GeneXpert? MTB/RIF without rifampicin resistance. All patients were prescribed the hydroxychloroquine-azithromycin combination and anti-tuberculosis treatment. Out of the nine patients, four recovered (44.4%) and five died (55.5%). Conclusion: COVID-19/TB coinfection had a low prevalence in our cohort, but was associated with a high mortality due to the frequent occurrence of severe forms of the disease.
References
[1]
World Health Organization (2020) WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19—11 March 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
[2]
Gupta, N., Ish, P., Gupta, A., Malhotra, N., Caminero, J.A., Singla, R., et al. (2020) A Profile of a Retrospective Cohort of 22 Patients with COVID-19 and Active/Treated Tuberculosis. European Respiratory Journal, 56, Article 2003408. https://doi.org/10.1183/13993003.03408-2020
[3]
Chen, Y., Wang, Y., Fleming, J., Yu, Y., Gu, Y., Liu, C., et al. (2020) Active or Latent Tuberculosis Increases Susceptibility to COVID-19 and Disease Severity. medRxiv. https://doi.org/10.1101/2020.03.10.20033795
[4]
DTM (COVID-19) Global Mobility Restriction Overview—3 January 2022. https://reliefweb.int/report/world/dtm-covid-19-global-mobility-restriction-overview-3-january-2022
[5]
Ministère de la santé et de l’action sociale du Sénégal. Communiqué 668 du 29 décembre 2021. https://www.sante.gouv.sn/sites/default/files/COMMUNIQUE%20668%20du%2029%2012%202021.pdf
[6]
Rapport OMS (2020) Tuberculose. https://www.who.int/fr/news-room/fact-sheets/detail/tuberculosis
[7]
PNT Sénégal. Rapport Annuel-PNT-2018. https://www.pnt.sn/wp-content/uploads/2023/03/RAPPORT-ANNUEL-PNT-2018.pdf
[8]
Migliori, G.B., Nardell, E., Yedilbayev, A., D’Ambrosio, L., Centis, R., Tadolini, M., et al. (2019) Reducing Tuberculosis Transmission: A Consensus Document from the World Health Organization Regional Office for Europe. European Respiratory Journal, 53, Article 1900391. https://doi.org/10.1183/13993003.00391-2019
[9]
Esposito, S., Principi, N., Leung, C.C. and Migliori, G.B. (2020) Universal Use of Face Masks for Success against COVID-19: Evidence and Implications for Prevention Policies. European Respiratory Journal, 55, Article 2001260. https://doi.org/10.1183/13993003.01260-2020
[10]
Rodriguez-Morales, A.J., Cardona-Ospina, J.A., Gutiérrez-Ocampo, E., Villamizar-Peña, R., Holguin-Rivera, Y., Escalera-Antezana, J.P., et al. (2020) Clinical, Laboratory and Imaging Features of COVID-19: A Systematic Review and Meta-Analysis. Travel Medicine and Infectious Disease, 34, Article 101623. https://doi.org/10.1016/j.tmaid.2020.101623
[11]
Crisan-Dabija, R., Grigorescu, C., Pavel, C.-A., Artene, B., Popa, I.V., Cernomaz, A., et al. (2020) Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes. Canadian Respiratory Journal, 2020, Article ID: 1401053. https://doi.org/10.1155/2020/1401053
[12]
Silva, D.R., Mello, F.C.Q., D’Ambrosio, L., Centis, R., Dalcolmo, M.P. and Migliori, G.B. (2021) Tuberculosis and COVID-19, the New Cursed Duet: What Differs between Brazil and Europe? Jornal Brasileiro de Pneumologia, 47, e20210044. https://doi.org/10.36416/1806-3756/e20210044
[13]
Li, T., Qiu, Z., Zhang, L., Han, Y., He, W., Liu, Z., et al. (2004) Significant Changes of Peripheral T Lymphocyte Subsets in Patients with Severe Acute Respiratory Syndrome. Journal of Infectious Diseases, 189, 648-651. https://doi.org/10.1086/381535
[14]
Rangaka, M.X., Cavalcante, S.C., Marais, B.J., Thim, S., Martinson, N.A., Swaminathan, S., et al. (2015) Controlling the Seedbeds of Tuberculosis: Diagnosis and Treatment of Tuberculosis Infection. The Lancet, 386, 2344-2353. https://doi.org/10.1016/S0140-6736(15)00323-2
[15]
Datta, S. and Evans, C.A. (2019) Healthy survival after tuberculosis. Lancet Infectious Diseases, 19, 1045-1047. https://doi.org/10.1016/S1473-3099(19)30387-1
[16]
Liu, W., Fontanet, A., Zhang, P.-H., Zhan, L., Xin, Z.-T., Tang, F., et al. (2006) Pulmonary Tuberculosis and SARS, China. Emerging Infectious Diseases, 12, 707-709. https://doi.org/10.3201/eid1204.050264
[17]
Golli, A.-L., Nitu, M.F., Turcu, F., Popescu, M., Ciobanu-Mitrache, L. and Olteanu, M. (2019) Tuberculosis Remains a Public Health Problem in Romania. International Journal of Tuberculosis and Lung Disease, 23, 226-231. https://doi.org/10.5588/ijtld.18.0270
[18]
Raoult, D., Zumla, A., Locatelli, F., Ippolito, G. and Kroemer, G. (2020) Coronavirus Infections: Epidemiological, Clinical and Immunological Features and Hypotheses. Cell Stress, 4, 66-75. https://doi.org/10.15698/cst2020.04.216
[19]
Bonadonna, L.V., Saunders, M.J., Zegarra, R., Evans, C., Alegria-Flores, K. and Guio, H. (2017) Why Wait? The Social Determinants Underlying Tuberculosis Diagnostic delay. PLOS ONE, 12, e0185018. https://doi.org/10.1371/journal.pone.0185018
[20]
Saunders, M.J., Tovar, M.A., Collier, D., Baldwin, M.R., Montoya, R., Valencia, T.R., et al. (2019) Active and Passive Case-Finding in Tuberculosis-Affected Households in Peru: A 10-Year Prospective Cohort Study. Lancet Infectious Diseases, 19, 519-528. https://doi.org/10.1016/S1473-3099(18)30753-9
[21]
Gupta, N., Agrawal, S., Ish, P., Mishra, S., Gaind, R., Usha, G., et al. (2020) Clinical and Epidemiologic Profile of the Initial COVID-19 Patients at a Tertiary Care Centre in India. Monaldi Archives for Chest Disease, 90,193-196. https://doi.org/10.4081/monaldi.2020.1294
[22]
Motta, I., Centis, R., D’Ambrosio, L., García-García, J.-M., Goletti, D., Gualano, G., et al. (2020) Tuberculosis, COVID-19 and Migrants: Preliminary Analysis of Deaths Occurring in 69 Patients from Two Cohorts. Pulmonology, 26, 233-240. https://doi.org/10.1016/j.pulmoe.2020.05.002
[23]
Davies, M.-A. (2020) HIV and Risk of COVID-19 Death: A Population Cohort Study from the Western Cape Province, South Africa. MedRxiv. https://doi.org/10.1101/2020.07.02.20145185
[24]
Tadolini, M., Codecasa, L.R., García-García, J.-M., Blanc, F.-X., Borisov, S., Alffenaar, J.-W., et al. (2020) Active Tuberculosis, Sequelae and COVID-19 Co-Infection: First Cohort of 49 Cases. European Respiratory Journal, 56, Article 2001398. https://doi.org/10.1183/13993003.01398-2020
[25]
Stochino, C., Villa, S., Zucchi, P., Parravicini, P., Gori, A. and Raviglione, M.C. (2020) Clinical Characteristics of COVID-19 and Active Tuberculosis Co-Infection in an Italian Reference Hospital. European Respiratory Journal, 56, Article 2001708. https://doi.org/10.1183/13993003.01708-2020
[26]
The TB/COVID-19 Global Study Group (2022) Tuberculosis and COVID-19 Co-Infection: Description of the Global Cohort. European Respiratory Journal, 59, Article 2102538. https://doi.org/10.1183/13993003.02538-2021
[27]
Pison, G. and Meslé, F. (2022) Les hommes meurent plus du Covid-19 que les femmes: De combien? et pourquoi? The Conversation, 1-6.
[28]
Long, R. and Schwartzman, K. (2014) La pathogénèse et la transmission de la tuberculose. In: Normes canadiennes pour la lutte antituberculeuse, 7e édition, Agence de la santé publique, Association pulmonaire, Société canadienne de thoracologie, Canada, 25-44.
[29]
Mazza-Stalder, J., Nicod, L. and Janssens, J.P. (2012) La Tuberculose Extrapulmonaire. Revue des Maladies Respiratoires, 29, 566-578. https://doi.org/10.1016/j.rmr.2011.05.021
[30]
Hu, Z., Song, C., Xu, C., Jin, G., Chen, Y., Xu, X., et al. (2020) Clinical Characteristics of 24 Asymptomatic Infections with COVID-19 Screened among Close Contacts in Nanjing, China. Science China Life Sciences, 63, 706-711. https://doi.org/10.1007/s11427-020-1661-4
[31]
Lee, J., Lim, J.K., Seo, H., Lee, S.Y., Choi, K.J., Yoo, S.S., et al. (2014) Clinical Relevance of Ground Glass Opacity in 105 Patients with Miliary Tuberculosis. Respiratory Medicine, 108, 924-930. https://doi.org/10.1016/j.rmed.2014.03.016
[32]
Diop, M., Ba, P.S., Tine, J.A.D., Fall, N.M., Youbong, T., Ndiaye, M., et al. (2021) Factors Associated with Death among Tuberculosis Patients in Dakar. Advances of Infectious Diseases, 11, 122-139. https://doi.org/10.4236/aid.2021.112013
[33]
Ouédraogo, A.R., Bougma, G., Baguiya, A., Sawadogo, A., Kaboré, P.R., Minougou, C.J., et al. (2021) Factors Associated with the Occurrence of Acute Respiratory Distress and Death in Patients with COVID-19 in Burkina Faso. Revue des Maladies Respiratoires, 38, 240-248. https://doi.org/10.1016/j.rmr.2021.02.001
